Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco A Mauri

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Oncotarget|June 26, 2018
Targeting autophagy sensitises lung cancer cells to Src family kinase inhibitorsEwa Rupniewska, Rajat Roy, Francesco A Mauri, et al.
Journal for Immunotherapy of Cancer|January 13, 2021
Transcriptional analysis of multiple ovarian cancer cohorts reveals prognostic and immunomodulatory consequences of ERV expressionMarina Natoli, John Gallon, Haonan Lu, et al.
British Journal of Cancer|May 8, 2019
Clinical implications of heterogeneity in PD-L1 immunohistochemical detection in hepatocellular carcinoma: the Blueprint-HCC studyDavid J Pinato, Francesco A Mauri, Paolo Spina, et al.
Cancers|May 5, 2021
Phenotypic Characteristics of the Tumour Microenvironment in Primary and Secondary Hepatocellular CarcinomaPetros Fessas, Paolo Spina, Renzo L Boldorini, et al.
American Journal of Respiratory and Critical Care Medicine|February 21, 2012
Doxycycline and HIV infection suppress tuberculosis-induced matrix metalloproteinasesNaomi F Walker, Simon O Clark, Tolu Oni, et al.
Journal of Hepatocellular Carcinoma|November 9, 2023
Mechanisms of Resistance to Immunotherapy in Hepatocellular CarcinomaGiulia Francesca Manfredi, Ciro Celsa, Chloe John, et al.
Journal for Immunotherapy of Cancer|October 1, 2021
Trans-arterial chemoembolization as a loco-regional inducer of immunogenic cell death in hepatocellular carcinoma: implications for immunotherapyDavid J Pinato, Sam M Murray, Alejandro Forner, et al.
JHEP Reports : Innovation in Hepatology|June 5, 2023
Integrated phenotyping of the anti-cancer immune response in HIV-associated hepatocellular carcinomaDavid J Pinato, Takahiro Kaneko, Antonio D'Alessio, et al.
Journal for Immunotherapy of Cancer|October 6, 2025
Preliminary qualification of a machine learning-based assessment of the tumor immune infiltrate as a predictor of outcome in patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumabBernhard Scheiner, Pasquale Lombardi, Antonio D'Alessio, et al.
Cancers|January 11, 2022
The Systemic Inflammatory Response Identifies Patients with Adverse Clinical Outcome from Immunotherapy in Hepatocellular CarcinomaAmbreen Muhammed, Claudia Angela Maria Fulgenzi, Sirish Dharmapuri, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Oncotarget|June 26, 2018
Targeting autophagy sensitises lung cancer cells to Src family kinase inhibitorsEwa Rupniewska, Rajat Roy, Francesco A Mauri, et al.
Journal for Immunotherapy of Cancer|January 13, 2021
Transcriptional analysis of multiple ovarian cancer cohorts reveals prognostic and immunomodulatory consequences of ERV expressionMarina Natoli, John Gallon, Haonan Lu, et al.
British Journal of Cancer|May 8, 2019
Clinical implications of heterogeneity in PD-L1 immunohistochemical detection in hepatocellular carcinoma: the Blueprint-HCC studyDavid J Pinato, Francesco A Mauri, Paolo Spina, et al.
Cancers|May 5, 2021
Phenotypic Characteristics of the Tumour Microenvironment in Primary and Secondary Hepatocellular CarcinomaPetros Fessas, Paolo Spina, Renzo L Boldorini, et al.
American Journal of Respiratory and Critical Care Medicine|February 21, 2012
Doxycycline and HIV infection suppress tuberculosis-induced matrix metalloproteinasesNaomi F Walker, Simon O Clark, Tolu Oni, et al.
Journal of Hepatocellular Carcinoma|November 9, 2023
Mechanisms of Resistance to Immunotherapy in Hepatocellular CarcinomaGiulia Francesca Manfredi, Ciro Celsa, Chloe John, et al.
Journal for Immunotherapy of Cancer|October 1, 2021
Trans-arterial chemoembolization as a loco-regional inducer of immunogenic cell death in hepatocellular carcinoma: implications for immunotherapyDavid J Pinato, Sam M Murray, Alejandro Forner, et al.
JHEP Reports : Innovation in Hepatology|June 5, 2023
Integrated phenotyping of the anti-cancer immune response in HIV-associated hepatocellular carcinomaDavid J Pinato, Takahiro Kaneko, Antonio D'Alessio, et al.
Journal for Immunotherapy of Cancer|October 6, 2025
Preliminary qualification of a machine learning-based assessment of the tumor immune infiltrate as a predictor of outcome in patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumabBernhard Scheiner, Pasquale Lombardi, Antonio D'Alessio, et al.
Cancers|January 11, 2022
The Systemic Inflammatory Response Identifies Patients with Adverse Clinical Outcome from Immunotherapy in Hepatocellular CarcinomaAmbreen Muhammed, Claudia Angela Maria Fulgenzi, Sirish Dharmapuri, et al.
Pageof 3